Establishment and validation of an in vitro liver model based extracellular matrix for hepatotoxicity prediction
Human & Experimental Toxicology · 2025
DOI: 10.1177/09603271251350797 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Human & Experimental Toxicology, 2025. Verfasst von Yue Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Safety Evalation of Drugs, National Institutes for Food and Drug Control, Beijing, China. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Extracellular Matrix, Liver, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the National Key Scientific Instrument and Equipment Development Projects of China during the 14th Five-year Plan Period, State Key Laboratory Project, Beijing Science and Technology Planning Project.
Abstract (Originalsprache)
Introduction
Three-dimension (3D) cell culture presents a promising alternative of drug-induced liver injury (DILI). To advance preclinical toxicology research, we developed an in vitro liver model using HepG2 for toxic evaluation.
Methods
The model was constructed based on the extracellular matrix. We assessed its long-term stability by monitoring the morphological change and anabolic capacity for 2 weeks, with functional analyses including albumin/urea production, lipid accumulation with Nile red staining, bile secretion with CLF signal, and transporter/enzyme expression including PGP, MRP2, BSEP, and CYP3A4.
Results
The model could be maintained for at least 10 days with enhanced hepatic synthetic functions indicated by albumin and urea nitrogen. Compared with the two-dimensional (2D) cultures, 3D culture exhibited enhanced lipid accumulation and biliary excretion. Key hepatic transporters PGP, MRP2, and BSEP and the metabolic enzyme cytochrome P450 3A4 were expressed between day 5 and 7. Single-exposure induced measurable apoptosis, mitochondrial disfunction and viability assays, while repeated treatment replicated impaired bile acid transport by reduced CLF intensity, and cytotoxicity with elevated AST, ALT, and decreased survival.
Discussion
Our 3D model surpasses conventional 2D systems in culture duration and functional complexity. It is suitable for DILI prediction after single- and repeated- treatment, which makes it particularly valuable for preclinical drug screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Safety Evalation of Drugs, National Institutes for Food and Drug Control, Beijing, China.
- National Institutes for Food and Drug Control, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
- School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China.
- State Key Laboratory of Drug Regulatory Science, Beijing, China.
ORCID-Profile: Yue Yu, Haodong Zhong, Qianyi Niu
Förderung
- the National Key Scientific Instrument and Equipment Development Projects of China during the 14th Five-year Plan Period
- State Key Laboratory Project
- Beijing Science and Technology Planning Project
Zitieren
APA
Yu, Y., Zhong, H., Niu, Q., Zhao, M., Li, B., & Zhou, X. (2025). Establishment and validation of an in vitro liver model based extracellular matrix for hepatotoxicity prediction. Human & Experimental Toxicology. https://doi.org/10.1177/09603271251350797
Vancouver
Yu Y, Zhong H, Niu Q, Zhao M, Li B, Zhou X. Establishment and validation of an in vitro liver model based extracellular matrix for hepatotoxicity prediction. Human & Experimental Toxicology. 2025. doi:10.1177/09603271251350797
BibTeX
@article{Yu2025,
author = {Yu, Yue and Zhong, Haodong and Niu, Qianyi and Zhao, Manman and Li, Bo and Zhou, Xiaobing},
title = {Establishment and validation of an in vitro liver model based extracellular matrix for hepatotoxicity prediction},
journal = {Human & Experimental Toxicology},
year = {2025},
doi = {10.1177/09603271251350797}
}
EUVIMED